Showing results (211-220 of 325) with videos related to

Sort By:
Pageof 33
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2021
2020 list of human papillomavirus assays suitable for primary cervical cancer screeningMarc Arbyn, Marie Simon, Eliana Peeters, et al.
Gynecologic Oncology|November 19, 2021
Adjuvant radiotherapy and local recurrence in vulvar cancer - a subset analysis of the AGO-CaRE-1 studyLinn Woelber, Katharina Prieske, Christine Zu Eulenburg, et al.
International Journal of Cancer|April 27, 2021
Association of genomic variants at PAX8 and PBX2 with cervical cancer riskDhanya Ramachandran, Yingying Wang, Peter Schürmann, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 28, 2023
Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7Sabine Heublein, Jacobus Pfisterer, Andreas du Bois, et al.
HLA|August 5, 2024
Validation and functional follow-up of cervical cancer risk variants at the HLA locusRieke Eisenblätter, Finja Seifert, Peter Schürmann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 28, 2026
Correlation of pelvic magnetic resonance imaging with diagnostic loop electrosurgical excision procedure/cone biopsy and hysterectomy pathology: an exploratory analysis of the CX.5/SHAPE trialMarie Plante, Janice S Kwon, Sven Mahner, et al.
Journal of Medical Virology|February 1, 2025
Genome-Wide Association Analyses of HPV16 and HPV18 Seropositivity Identify Susceptibility Loci for Cervical CancerTheresa Beckhaus, Linda Kachuri, Taishi Nakase, et al.
Journal of Medical Virology|September 2, 2024
Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screeningMarc Arbyn, Kate Cuschieri, Jesper Bonde, et al.
International Journal of Cancer|March 17, 2021
Classification of high-grade cervical intraepithelial neoplasia by p16ink4a , Ki-67, HPV E4 and FAM19A4/miR124-2 methylation status demonstrates considerable heterogeneity with potential consequences for managementFrederique J Vink, Stèfanie Dick, Daniëlle A M Heideman, et al.
The Journal of Infectious Diseases|June 8, 2017
Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized TrialLi-Min Huang, Thanyawee Puthanakit, Chiu Cheng-Hsun, et al.
Pageof 33